List of Tables
Table 1. Global Opioids Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Opioids Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Opioids Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Opioids Drug Sales (M Units) of Key Manufacturers (2021–2026)
Table 5. Global Opioids Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Opioids Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Opioids Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Opioids Drug Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Opioids Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Opioids Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Opioids Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Opioids Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Opioids Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Opioids Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Opioids Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Opioids Drug Sales by Region (M Units), 2021–2026
Table 18. Global Opioids Drug Sales Market Share by Region (2021–2026)
Table 19. Global Opioids Drug Sales by Region (M Units), 2027–2032
Table 20. Global Opioids Drug Sales Market Share by Region (2027–2032)
Table 21. Global Opioids Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Opioids Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Opioids Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Opioids Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Opioids Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Opioids Drug Sales by Country (M Units), 2021–2026
Table 27. North America Opioids Drug Sales by Country (M Units), 2027–2032
Table 28. North America Opioids Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Opioids Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Opioids Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Opioids Drug Sales by Country (M Units), 2021–2026
Table 32. Europe Opioids Drug Sales by Country (M Units), 2027–2032
Table 33. Europe Opioids Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Opioids Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Opioids Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Opioids Drug Sales by Region (M Units), 2021–2026
Table 37. Asia Pacific Opioids Drug Sales by Region (M Units), 2027–2032
Table 38. Asia Pacific Opioids Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Opioids Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Opioids Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Opioids Drug Sales by Country (M Units), 2021–2026
Table 42. Latin America Opioids Drug Sales by Country (M Units), 2027–2032
Table 43. Latin America Opioids Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Opioids Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Opioids Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Opioids Drug Sales by Country (M Units), 2021–2026
Table 47. Middle East and Africa Opioids Drug Sales by Country (M Units), 2027–2032
Table 48. Middle East and Africa Opioids Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Opioids Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Opioids Drug Sales (M Units) by Type (2021–2026)
Table 51. Global Opioids Drug Sales (M Units) by Type (2027–2032)
Table 52. Global Opioids Drug Sales Market Share by Type (2021–2026)
Table 53. Global Opioids Drug Sales Market Share by Type (2027–2032)
Table 54. Global Opioids Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Opioids Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Opioids Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Opioids Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Opioids Drug Price (USD/Unit) by Type (2021–2026)
Table 59. Global Opioids Drug Price (USD/Unit) by Type (2027–2032)
Table 60. Global Opioids Drug Sales (M Units) by Application (2021–2026)
Table 61. Global Opioids Drug Sales (M Units) by Application (2027–2032)
Table 62. Global Opioids Drug Sales Market Share by Application (2021–2026)
Table 63. Global Opioids Drug Sales Market Share by Application (2027–2032)
Table 64. Global Opioids Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Opioids Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Opioids Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Opioids Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Opioids Drug Price (USD/Unit) by Application (2021–2026)
Table 69. Global Opioids Drug Price (USD/Unit) by Application (2027–2032)
Table 70. Teva Company Information
Table 71. Teva Description and Business Overview
Table 72. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Teva Opioids Drug Product
Table 74. Teva Recent Developments/Updates
Table 75. Purdue Pharma Company Information
Table 76. Purdue Pharma Description and Business Overview
Table 77. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Purdue Pharma Opioids Drug Product
Table 79. Purdue Pharma Recent Developments/Updates
Table 80. Mallinckrodt Company Information
Table 81. Mallinckrodt Description and Business Overview
Table 82. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Mallinckrodt Opioids Drug Product
Table 84. Mallinckrodt Recent Developments/Updates
Table 85. Amneal Pharma Company Information
Table 86. Amneal Pharma Description and Business Overview
Table 87. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Amneal Pharma Opioids Drug Product
Table 89. Amneal Pharma Recent Developments/Updates
Table 90. Collegium Company Information
Table 91. Collegium Description and Business Overview
Table 92. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Collegium Opioids Drug Product
Table 94. Collegium Recent Developments/Updates
Table 95. J&J Company Information
Table 96. J&J Description and Business Overview
Table 97. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. J&J Opioids Drug Product
Table 99. J&J Recent Developments/Updates
Table 100. Endo Company Information
Table 101. Endo Description and Business Overview
Table 102. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Endo Opioids Drug Product
Table 104. Endo Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Pfizer Opioids Drug Product
Table 109. Pfizer Recent Developments/Updates
Table 110. INSYS Company Information
Table 111. INSYS Description and Business Overview
Table 112. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. INSYS Opioids Drug Product
Table 114. INSYS Recent Developments/Updates
Table 115. Mylan Company Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. Mylan Opioids Drug Product
Table 119. Mylan Recent Developments/Updates
Table 120. Hikma Company Information
Table 121. Hikma Description and Business Overview
Table 122. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Hikma Opioids Drug Product
Table 124. Hikma Recent Developments/Updates
Table 125. Egalet Company Information
Table 126. Egalet Description and Business Overview
Table 127. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Egalet Opioids Drug Product
Table 129. Egalet Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Opioids Drug Distributors List
Table 133. Opioids Drug Customers List
Table 134. Opioids Drug Market Trends
Table 135. Opioids Drug Market Drivers
Table 136. Opioids Drug Market Challenges
Table 137. Opioids Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Opioids Drug
Figure 2. Global Opioids Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Opioids Drug Market Share by Type: 2025 & 2032
Figure 4. Oxycodone Product Picture
Figure 5. Hydromorphone Product Picture
Figure 6. Codeine Product Picture
Figure 7. Fentanyl Product Picture
Figure 8. Global Opioids Drug Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Opioids Drug Market Share by Application: 2025 & 2032
Figure 10. Pain Relief
Figure 11. Anesthesia
Figure 12. Others
Figure 13. Global Opioids Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Opioids Drug Market Size (US$ Million), 2021–2032
Figure 15. Global Opioids Drug Sales (M Units), 2021–2032
Figure 16. Global Opioids Drug Average Price (USD/Unit), 2021–2032
Figure 17. Opioids Drug Report Years Considered
Figure 18. Opioids Drug Sales Share by Manufacturers in 2025
Figure 19. Global Opioids Drug Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Opioids Drug Players: Market Share by Revenue in Opioids Drug in 2025
Figure 21. Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Opioids Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Opioids Drug Sales Market Share by Country (2021–2032)
Figure 24. North America Opioids Drug Revenue Market Share by Country (2021–2032)
Figure 25. U.S. Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Opioids Drug Sales Market Share by Country (2021–2032)
Figure 28. Europe Opioids Drug Revenue Market Share by Country (2021–2032)
Figure 29. Germany Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Opioids Drug Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Opioids Drug Revenue Market Share by Region (2021–2032)
Figure 36. China Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Indonesia Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Thailand Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Malaysia Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Opioids Drug Sales Market Share by Country (2021–2032)
Figure 46. Latin America Opioids Drug Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Opioids Drug Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Opioids Drug Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Opioids Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Opioids Drug by Type (2021–2032)
Figure 56. Global Revenue Market Share of Opioids Drug by Type (2021–2032)
Figure 57. Global Opioids Drug Price (USD/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Opioids Drug by Application (2021–2032)
Figure 59. Global Revenue Market Share of Opioids Drug by Application (2021–2032)
Figure 60. Global Opioids Drug Price (USD/Unit) by Application (2021–2032)
Figure 61. Opioids Drug Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
